نتایج جستجو برای: breakthrough bleeding

تعداد نتایج: 69559  

Journal: :Nature Reviews Genetics 2006

Journal: :Nature Reviews Neuroscience 2007

Journal: :Journal of Internal Medicine 1989

Journal: :Nature Reviews Drug Discovery 2005

Journal: :Physics in Technology 1987

Journal: :Reproductive Health 2004
Regina Kulier Frans M Helmerhorst Nandita Maitra A Metin Gülmezoglu

BACKGROUND: The progestogen component of oral contraceptives (OCs) has undergone changes since it was recognized that their chemical structure can influence the spectrum of minor adverse and beneficial effects. METHODS: The objective of this review was to evaluate currently available low-dose OCs containing ethinylestradiol and different progestogens in terms of contraceptive effectiveness, cyc...

2015
Roberto Furlan Sangeeta Krishnan Jeffrey Vietri

INTRODUCTION New longer-acting factor products will potentially allow for less frequent infusion in prophylactic treatment of hemophilia. However, the role of administration frequency relative to other treatment attributes in determining preferences for prophylactic hemophilia treatment regimens is not well understood. AIM To identify the relative importance of frequency of administration, ef...

Journal: :Human reproduction 2005
P A W Rogers F Martinez J E Girling F Lederman L Cann E Farrell F Tresserra N Patel

BACKGROUND The aim of this study was to quantify blood vessel density (BVD) and immunoreactive vascular endothelial growth factor (VEGF) levels in endometrial biopsies taken from women suffering breakthrough bleeding (BTB) under different exogenous hormonal regimes. METHODS Endometrial biopsies from women in Melbourne with BTB were divided into four groups: combined-continuous hormone therapy...

Journal: :Haemophilia : the official journal of the World Federation of Hemophilia 2017
G Kenet A Oladapo J D Epstein C Thompson A Novack D J Nugent

INTRODUCTION The International Immune Tolerance Study (I-ITI) demonstrated comparable success rates between low (FVIII 50 IU/kg/TIW) and high dose (FVIII 200 IU/kg/day) regimens. While costlier, the high dose ITI regimen achieved shorter time-to-treatment success with fewer bleeding episodes compared to the low dose ITI regimen. Adding bypassing agent prophylaxis (BAP) to a low dose ITI regimen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید